For that purpose, we blocked CTLA-4 on the surface of CLL cells using monoclonal anti-CTLA-4 antibodies to assess the expression of cyclins D2 and D3, and p27KIP1 protein. This evidence concerns the gene CCND2 and B-cell chronic lymphocytic leukemia.